Literature DB >> 8369942

Reappraisal of radical local excision for carcinoma of the rectum.

M R Lock1, J K Ritchie, P R Hawley.   

Abstract

Outcome in all 167 patients treated by radical local excision for rectal carcinoma between 1948 and 1984 at St Mark's Hospital was assessed in terms of the original tumour differentiation except for 15 patients with incomplete follow-up or ungraded tumours. Fifty-six of the 152 patients had low-grade tumours, with one death from carcinoma in this group. Of 81 patients with average-grade tumours, ten died from carcinoma of the rectum: two after early reoperation and eight following recurrence. Six of 15 patients with high-grade tumours underwent early reoperation and three of these died from carcinoma. Among the nine patients who did not undergo early reoperation there were three related deaths (two from carcinoma, one after rectal excision for recurrence). Local excision remains a valid therapy for suitable patients with low-grade tumours but is not recommended for those with average-grade lesions. The necessity for early reoperation in patients with high-grade tumours is questioned.

Entities:  

Mesh:

Year:  1993        PMID: 8369942     DOI: 10.1002/bjs.1800800747

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  3 in total

1.  Local excision of rectal cancer without adjuvant therapy: a word of caution.

Authors:  J Garcia-Aguilar; A Mellgren; P Sirivongs; D Buie; R D Madoff; D A Rothenberger
Journal:  Ann Surg       Date:  2000-03       Impact factor: 12.969

2.  Transanal local resection for benign and malignant rectal tumours.

Authors:  E E Piccinini; G Ugolini; G Rosati; A Conti
Journal:  Int J Colorectal Dis       Date:  1995       Impact factor: 2.571

3.  Validation of the effects of TGF-β1 on tumor recurrence and prognosis through tumor retrieval and cell mechanical properties.

Authors:  Tsung-Hsien Wu; Yu-Wei Chou; Pei-Hung Chiu; Ming-Jer Tang; Chun-Wen Hu; Ming-Long Yeh
Journal:  Cancer Cell Int       Date:  2014-03-03       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.